# Dinalbuphine

## Naldebain ER inj 150mg/2mL

| TAH Drug Code      | [INALD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INALD)                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Used for the prevention and management of moderate to severe acute pain after surgery through preemptive dosing.                                                                                                                                              |
| Dosing             | IM: Single dose 150mg                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                 |
| Contraindications  | This product is an intramuscular injection and must not be used for intravenous injection. It is contraindicated in patients who are allergic to the active ingredient or any excipients (dinalbuphine sebacate, nalbuphine, sesame oil, or benzyl benzoate). |
| Adverse Effects    | >10%: Central nervous system: Sedation (36%) 1% to 10%: Central nervous system: Dizziness (5%), headache (3%) Dermatologic: Cold and clammy skin (9%) Gastrointestinal: Nausea and vomiting (6%), xerostomia (4%)                                             |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                       |
| Lactation          | Unknown                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/dinalbuphine-drug-information)                                                                                                                                                                                   |

